[1] PATEL H, ABDULJABBAR R, LAI C F, et al. Expression of CDK7, cyclin H, and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor- positive breast cancer[J]. Clin Cancer Res, 2016, 22(23): 5929-5938. [2] MURALI A, NALINAKUMARI K R, THOMAS S, et al. Association of single nucleotide polymorphisms in cell cycle regulatory genes with oral cancer susceptibility[J]. Br J Oral Maxillofac Surg, 2014, 52(7): 652-658. [3] SANTOS L S, GOMES B C, GOUVEIA R, et al. The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer[J]. Oncol Rep, 2013, 30(5): 2458- 2466. [4] MA H X, CHEN J P, PAN S Y, et al. Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population[J]. Lung Cancer, 2011, 73(1): 32-37. [5] SUN X H, HOU W G, ZHAO H X, et al. Single nucleotide polymorphisms in the NER pathway and clinical outcome of patients with bone malignant tumors[J]. Asian Pac J Cancer Prev, 2013, 14(3): 2049-2052. [6] MA J, MÖLLSTEN A, PRÁZNY M, et al. Genetic influences of the intercellular adhesion molecule 1(ICAM-1) gene polymorphisms in development of Type 1 diabetes and diabetic nephropathy[J]. Diabet Med, 2006, 23(10): 1093-1099. [7] GONI L, CUERVO M, MILAGRO F I, et al. A genetic risk tool for obesity predisposition assessment and personalized nutrition implementation based on macronutrient intake[J]. Genes Nutr, 2015, 10(1): 445. [8] HASHEMI M, BAHARI G, NADERI M, et al. Association of lnc-LAMC2-1: 1 rs2147578 and CASC8 rs10505477 polymorphisms with risk of childhood acute lymphoblastic leukemia[J]. Asian Pac J Cancer Prev, 2016, 17(11): 4985- 4989. [9] WANG T W, WANG S H, DUAN X R, et al. Application of created restriction site PCR-RFLP to identify POT1 gene polymorphism[J]. Biochemistry (Mosc), 2016, 81(6): 624-627. [10] LI Y C, JIN G F, WANG H F, et al. Polymorphisms of CAK genes and risk for lung cancer: a case-control study in Chinese population[J]. Lung Cancer, 2007, 58(2): 171-183. [11] PHELAN J, O'SULLIVAN D M, MACHADO D, et al. The variability and reproducibility of whole genome sequencing technology for detecting resistance to anti-tuberculous drugs[J]. Genome Med, 2016, 8(1): 132. [12] KAEWBUBPA W, AREEPIUM N, SRIURANPONG V. Effect of the ERCC1 (C118T) polymorphism on treatment response in advanced non-small cell lung cancer patients undergoing platinum-based chemotherapy[J]. Asian Pac J Cancer Prev, 2016, 17(11): 4917-4920. [13] ZHOU Y F, ZHANG J, LI Z X, et al. Association of liver X receptor α (LXRα) gene polymorphism and coronary heart disease, serum lipids and glucose levels[J]. Lipids Health Dis, 2014, 13: 34. [14] SHARIF A, KHEIRKHAH D, REZA SHARIF M, et al. ABCB1- C3435T polymorphism and breast cancer risk: a case- control study and a meta-analysis[J]. J BUON, 2016, 21(6): 1433- 1441. [15] 刘伟, 董娜, 田彦辉, 等. 单核苷酸多态性检测技术概述[J]. 生物学教学, 2020, 45(8): 6-9. |